168 related articles for article (PubMed ID: 20880176)
21. Colorectal carcinoma screening procedure use among primary care patients.
Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G
Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119
[TBL] [Abstract][Full Text] [Related]
22. Determinants of participation in colorectal cancer screening with faecal occult blood testing.
von Euler-Chelpin M; Brasso K; Lynge E
J Public Health (Oxf); 2010 Sep; 32(3):395-405. PubMed ID: 20015868
[TBL] [Abstract][Full Text] [Related]
23. Results of a repeat television-advertised mass screening program for colorectal cancer using fecal occult blood tests.
McGarrity TJ; Long PA; Peiffer LP
Am J Gastroenterol; 1990 Mar; 85(3):266-70. PubMed ID: 2309678
[TBL] [Abstract][Full Text] [Related]
24. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
Hofbauer F; Mach K; Egermann G
Wien Klin Wochenschr; 1991; 103(10):288-95. PubMed ID: 1858377
[TBL] [Abstract][Full Text] [Related]
25. Does fecal occult blood test have a place for colorectal cancer screening in China in 2006?
Sung J
Am J Gastroenterol; 2006 Feb; 101(2):213-5. PubMed ID: 16454819
[No Abstract] [Full Text] [Related]
26. Early detection of colorectal cancer with faecal occult blood test screening.
Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
[TBL] [Abstract][Full Text] [Related]
27. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screening.
Berchi C; Guittet L; Bouvier V; Launoy G
Int J Technol Assess Health Care; 2010 Jan; 26(1):48-53. PubMed ID: 20059780
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test.
Lejeune C; Dancourt V; Arveux P; Bonithon-Kopp C; Faivre J
Int J Technol Assess Health Care; 2010 Jan; 26(1):40-7. PubMed ID: 20059779
[TBL] [Abstract][Full Text] [Related]
30. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
[TBL] [Abstract][Full Text] [Related]
31. Fecal-occult-blood test screening for colorectal cancer.
Zacks M
J Fam Pract; 1997 Mar; 44(3):247-8. PubMed ID: 9071239
[No Abstract] [Full Text] [Related]
32. "It's a small price to pay for life": faecal occult blood test (FOBT) screening for colorectal cancer, perceived barriers and facilitators.
Reeder AI
N Z Med J; 2011 Mar; 124(1331):11-7. PubMed ID: 21725408
[TBL] [Abstract][Full Text] [Related]
33. Population colorectal cancer screening with fecal occult blood test.
Rennert G; Rennert HS; Miron E; Peterburg Y
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
[TBL] [Abstract][Full Text] [Related]
34. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
[TBL] [Abstract][Full Text] [Related]
35. Colorectal cancer screening through detection of fecal occult blood in a controlled health zone.
Tárraga P; García-Olmo D; Celada A; García-Molinero Mf; Divison JA; Casado C
Rev Esp Enferm Dig; 1999 May; 91(5):335-44. PubMed ID: 10362875
[TBL] [Abstract][Full Text] [Related]
36. Potential impact of population-based colorectal cancer screening in Canada.
Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E
Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756
[TBL] [Abstract][Full Text] [Related]
37. [Faecal occult blood test and mass screening for colorectal cancer].
Hiwatashi N; Shimada T
Nihon Rinsho; 2003 Sep; 61 Suppl 7():201-6. PubMed ID: 14574882
[No Abstract] [Full Text] [Related]
38. Factors associated with initial participation in a population-based screening for colorectal cancer in Catalonia, Spain: a mixed-methods study.
García M; Borràs JM; Milà N; Espinàs JA; Binefa G; Fernández E; Farré A; Pla M; Cardona A; Moreno V
Prev Med; 2011; 52(3-4):265-7. PubMed ID: 21295061
[TBL] [Abstract][Full Text] [Related]
39. Population-based fecal occult blood screening for colon cancer: will the benefits outweigh the harm?
Marshall KG
CMAJ; 2000 Sep; 163(5):545-6; discussion 547. PubMed ID: 11006766
[No Abstract] [Full Text] [Related]
40. Psychological distress following fecal occult blood test in colorectal cancer screening--a population-based study.
Brasso K; Ladelund S; Frederiksen BL; Jørgensen T
Scand J Gastroenterol; 2010 Oct; 45(10):1211-6. PubMed ID: 20443744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
